ImmunityBio inks $320m deal to advance bladder cancer drug and boost pipeline

1 year ago 75

The deal will see ImmunityBio receiving an upfront $210m combination of equity and royalty financing from Oberland.

1. Homepage
2. Cancer
3. ImmunityBio inks $320m deal to advance bladder cancer drug and boost pipeline